Emerging evidence suggests that ECM-associated CAFs may exist along a functional continuum with myCAFs, shaped by factors such as transforming growth factor-beta (TGF-β) signaling, tissue stiffness, and tumor-derived cues [20]. The gene discussed is TGFB1; the disease is neoplasm.